ClinicalTrials.gov
public full text
Public Domain
Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery
We conducted a multicenter, randomized, placebo-controlled trial of Cylexin, an inhibitor of the attachment of white blood cells to the endothelium. Our study population was neonates and infants undergoing hypothermic cardiopulmonary bypass during surgical repair or palliation of congenital heart defects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Postoperative infections after cardiac surgery with cardiopulmonary bypass - incidence, performance of diagnostic procedures, and predictive factors.#1360151
- Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent#1352849
- Cytosorb Therapy in Cardiac Surgery#892793
- Risk Factors for Deep Sternal Wound Infection After Coronary Artery Bypass Grafting#1369599
- Calcium Levels in Major Trauma#833032
Record · ID 1382147
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive